Document is current
Any future updates will be listed below
-
Authors
Fu, Weijia
Rothstein, Joseph H.
Melander, Olle
Lilja, Hans https://orcid.org/0000-0001-5871-7846
Sieh, Weiva https://orcid.org/0000-0003-0085-1190
Song, Xiaoyu https://orcid.org/0000-0003-1909-6244
Klein, Robert J. https://orcid.org/0000-0003-3539-5391
- License Information
-
More Information
Article History
Received: 10 July 2025
Revised: 15 April 2026
Accepted: 21 May 2026
First Online: 20 June 2026
Competing interests
: HL is named on a patent for a statistical method to detect prostate cancer commercialized by OPKO Health (4KScore). HL receives royalties from sales of the test, and has stock in OPKO Health. HL serves on the Scientific Advisory Board for Fujirebio Diagnostics Inc and owns stock in Diaprost AB and Acousort AB.
: This study was reviewed and approved by the Institutional Review Board of the Icahn School of Medicine at Mount Sinai (STUDY-20-01538). Informed consent was obtained from all subjects.
